KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Cash from Financing Activities (2016 - 2026)

Globus Medical filings provide 15 years of Cash from Financing Activities readings, the most recent being $13.2 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 77.88% to $13.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$679.2 million, a 2352.2% decrease, with the full-year FY2025 number at -$679.2 million, down 2352.2% from a year prior.
  • Cash from Financing Activities hit $13.2 million in Q4 2025 for Globus Medical, up from -$32.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $59.7 million in Q4 2024 to a low of -$635.4 million in Q1 2025.
  • Median Cash from Financing Activities over the past 5 years was $4.5 million (2022), compared with a mean of -$49.7 million.
  • Biggest five-year swings in Cash from Financing Activities: surged 1428.54% in 2022 and later tumbled 4036.09% in 2024.
  • Globus Medical's Cash from Financing Activities stood at -$1.0 million in 2021, then surged by 1428.54% to $13.6 million in 2022, then crashed by 1845.79% to -$237.3 million in 2023, then skyrocketed by 125.18% to $59.7 million in 2024, then plummeted by 77.88% to $13.2 million in 2025.
  • The last three reported values for Cash from Financing Activities were $13.2 million (Q4 2025), -$32.0 million (Q3 2025), and -$24.9 million (Q2 2025) per Business Quant data.